0001104659-22-054933.txt : 20220606 0001104659-22-054933.hdr.sgml : 20220606 20220503060105 ACCESSION NUMBER: 0001104659-22-054933 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc. CENTRAL INDEX KEY: 0001710072 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821725586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 3415 COLORADO AVE. CITY: BOULDER STATE: CO ZIP: 80303 BUSINESS PHONE: 303-735-8373 MAIL ADDRESS: STREET 1: 3415 COLORADO AVE. CITY: BOULDER STATE: CO ZIP: 80303 CORRESP 1 filename1.htm

 

Edgewise Therapeutics, Inc.

3415 Colorado Ave

Boulder, Colorado 80303

 

May 3, 2022

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re:Edgewise Therapeutics, Inc.
  Registration Statement on Form S-3
  Filed April 1, 2022
  File No. 333-264083
   
  Acceleration Request
  Requested Date: May 5, 2022
  Requested Time: 4:00 p.m. Eastern Time,
    or as soon thereafter as practicable

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Edgewise Therapeutics, Inc. (the “Company”) hereby respectfully requests that the above-referenced Registration Statement on Form S-3 (File No. 333-264083) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.

 

Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, by calling Melissa Rick at (650) 849-3059.

 

Please direct any questions or comments regarding this acceleration request to Melissa Rick at (650) 849-3059.

 

[Signature Page Follows]

 

 

 

  Very truly yours,
   
  Edgewise Therapeutics, Inc.
   
  /s/ John Moore
   
  John Moore
  General Counsel

 

cc:Melissa Rick, Wilson Sonsini Goodrich & Rosati, Professional Corporation

 

[Signature Page to the Company’s Acceleration Request]